Literature DB >> 2829070

Breast milk radioactivity following injection of 99Tcm-pertechnetate and 99Tcm-glucoheptonate.

P J Mountford1, A J Coakley.   

Abstract

Measurements were made of the concentration of radioactivity in the breast milk of two patients: one following 100 MBq (2.7 mCi) 99Tcm-pertechnetate administration, and the other following administration of 550 MBq (15 mCi) 99Tcm-glucoheptonate. The fractional activity concentrations in the former case were about two orders of magnitude greater than in the latter and the effective half lives of secretion were 3 and 4 h, respectively. An infant breast fed without interruption would have ingested 5.2 and 0.055% of the 99Tcm administered with pertechnetate and with glucoheptonate, respectively. The former fractional ingestion was compatible with the larger value expected following pertechnetate injection without perchlorate pretreatment, and would have produced an effective dose equivalent to the infant of 1.5 mSV. An interruption to feeding of 12 h would reduce this dose to 0.2 mSV. It was concluded that breast feeding need not be interrupted after injection of 99Tcm-glucoheptonate other than for a short period of reassurance.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2829070     DOI: 10.1097/00006231-198710000-00011

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  2 in total

Review 1.  The excretion of radiopharmaceuticals in human breast milk: additional data and dosimetry.

Authors:  S Rubow; J Klopper; H Wasserman; B Baard; M van Niekerk
Journal:  Eur J Nucl Med       Date:  1994-02

2.  Excretion of radionuclides in human breast milk after nuclear medicine examinations. Biokinetic and dosimetric data and recommendations on breastfeeding interruption.

Authors:  Sigrid Leide-Svegborn; Lars Ahlgren; Lennart Johansson; Sören Mattsson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-06       Impact factor: 9.236

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.